Apoxis is a startup based in Switzerland, most recent round Acquired.
Apoxis is a company headquartered in Switzerland. Apoxis has been acquired.
Apoxis SA was a Swiss company focused on the discovery and development of therapeutics targeting cell death, inflammation, and angiogenesis for the treatment of cancer and autoimmune diseases before merging with TopoTarget A/S.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.